Psoriasis is a chronic, immune-mediated, inflammatory disease that is pathogenically driven
by proinflammatory cytokines. This article reviews the immunologic role of interleukin (IL)-17 …

The skin is one of the most important organs in the body, providing integrity and acting as a
barrier to exclude microbes, allergens and chemicals. However, chronic skin inflammation …

The pace of antibody therapeutics development accelerated in 2017, and this faster pace is
projected to continue through 2018. Notably, the annual number of antibody therapeutics …

Background Patients with psoriasis value rapid and complete skin clearance. No head‐to‐
head studies have focused on early responses to interleukin (IL)‐17 vs. IL‐23 inhibitors …

В монографии приведены сведения по роли цитокинов в регуляции физиологических
процессов, защитных реакций организма и в патогенезе иммунопатологических …

The temporal association had been reported between vaccination and exacerbation of
psoriasis, and episodes of psoriasis flare-up have recently been attributed to COVID-19 …

Research in the pathogenesis of inflammatory skin diseases, such as skin dermatitis and
psoriasis, has experienced some relevant breakthroughs in recent years. The understanding …

Introduction Deucravacitinib is an oral, selective tyrosine kinase 2 inhibitor that
demonstrated therapeutic benefit in a Phase 2 clinical trial of adults with moderate to severe …

Skin is an important organ that mainly functions as a barrier. Skin diseases can damage a
person's self-confidence and reduce their willingness to socialize, as well as their social …

Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis
(MS) that shares many features with the human disease. This review will focus on the role of …